C/EBPβ is stabilized and activated by S-glutathionylation in adipocytes [53] and may, therefore, be one of the targets by which Glrx decreases inflammatory mediators in NASH. This evidence concerns the gene GLRX and metabolic dysfunction-associated steatohepatitis.